Allogene Therapeutics, Inc. (ALLO)
2.46
+0.39
(+18.84%)
USD |
NASDAQ |
Mar 23, 15:40
Allogene Therapeutics EPS Diluted (Quarterly) : -0.1717 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.172 |
| Inovio Pharmaceuticals, Inc. | 0.0546 |
| Vaxart, Inc. | 0.2289 |
| Capricor Therapeutics, Inc. | -0.6176 |
| Agenus, Inc. | -0.301 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.81M |
| Total Expenses (Quarterly) | 38.81M |
| Enterprise Value | 337.66M |
| Earnings Yield | -35.29% |
| Normalized Earnings Yield | -34.98 |